ST華鈺(601020.SH):道衡投資與長城資本和濰坊投資的股權轉讓協議自動終止
格隆匯8月6日丨ST華鈺(601020.SH)公佈,此前披露,公司控股股東西藏道衡投資有限公司(“道衡投資”)將其持有的公司55,514,826股無限售流通股(佔公司總股本的9.9999%)通過協議轉讓的方式轉讓給長城資本管理有限公司(“長城資本”)和濰坊泰達城鄉建設投資有限公司(“濰坊投資”)(或其指定關聯方)擬共同設立的長城濰坊基金。
公司於近日接到道衡投資發來的《終止長城濰坊基金合作吿知函》,獲悉:因長城濰坊基金未能在雙方合作協議簽署日後90個工作日內通過中國基金業協會產品備案,道衡投資與長城資本和濰坊投資的股權轉讓協議自動終止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.